Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up von Laftavi, M.R, Alnimri, M, Weber-Shrikant, E, Kohli, R, Said, M, Patel, S, Pankewycz, O

Volltext

Low-Dose Thymoglobulin Use in Elderly Renal Transplant Recipients Is Safe and Effective Induction Therapy von Laftavi, M.R, Patel, S, Soliman, M.R, Alnimri, M, Kohli, R, Said, M, Pankewycz, O

Volltext

Obesity in Renal Transplantation: The Role of Induction Therapy on Long-Term Outcomes von Patel, S, Pankewycz, O, Kohli, R, Said, M, Alnimri, M, Feng, L, Laftavi, M.R

Volltext

Low-Dose Rabbit Antithymocyte Globulin Induction Therapy Results in Prolonged Selective Lymphocyte Depletion Irrespective of Maintenance Immunosuppression von Pankewycz, O, Leca, N, Kohli, R, Wallace, P.K, Said, M, Feng, L, Alnimri, M, Patel, S, Laftavi, M.R

Volltext

Conversion to Low-Dose Tacrolimus or Rapamycin 3 Months After Kidney Transplantation: A Prospective, Protocol Biopsy-Guided Study von Pankewycz, O, Leca, N, Kohli, R, Weber-Shrikant, E, Said, M, Alnimri, M, Feng, L, Patel, S, Laftavi, M.R

Volltext

African-American Women and Older Patients Are at Risk for a Greater Decline in Renal Function Following Living Kidney Donation von Alnimri, M, Laftavi, M.R, Kohli, R, Said, M, Feng, L, Patel, S, Pankewycz, O

Volltext

Mycophenolic Acid Dose Reductions Result in Poor Long-Term Renal Allograft Survival: Comparison Between Mycophenolate Sodium and Mycophenolate Mofetil von Laftavi, M.R, Hai, F, Laftavi, H, Feng, L, Said, M, Patel, S, Kohli, R, Alnimri, M, Dayton, M, Pankewycz, O

Volltext

Acute myocardial infarction patients treated by primary angioplasty lack personal control over their illness and display less risk factor modification compared to other treatment m... von Al-Smadi, A., Fitzsimmons, D., Slater, P., Alnimri, M., Donnelly, P., Niall, H.

Volltext

SAT-077 SHORT-TERM POST-TRANSPLANT OUTCOMES OF KIDNEYS FROM DONORS WITH POSITIVE BLOOD AND/OR URINE CULTURES von CHEN, L., Alman, K., Alnimri, M., Kamiyama, D., Francalacci, L., Zhu, E., Donnelley, M., Clayton, N., De Mattos, A., Brown, J.

Volltext

CONVERSION TO LOW DOSE TACROLIMUS OR RAPAMYCIN 3 MONTHS AFTER KIDNEY TRANSPLANT: A PROSPECTIVE, PROTOCOL BIOPSY GUIDED STUDY: 106 von Pankewycz, O., Said, M., Feng, L., Patel, S. K., Alnimri, M., Kohli, R., Laftavi, M. R.

Volltext

LOW DOSE RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY RESULTS IN PROLONGED SELECTIVE CD4 T CELL DEPLETION IRRESPECTIVE OF MAINTENANCE IMMUNOSUPPRESSION: 130 von Pankewycz, O., Kohli, R., Wallace, P. K., Said, M., Feng, L., Patel, S. K., Alnimri, M., Laftavi, M. R.

Volltext

LOW DOSE RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION IN LOW RISK RENAL TRANSPLANT RECIPIENTS: 8 YEARS FOLLOW UP: 85 von Laftavi, M. R., Patel, S. K., Feng, L., Said, M., Laftavi, H., Kohli, R., Alnimri, M., Pankewycz, O.

Volltext

LOW DOSE RABBIT ANTI-THYMOCYTE GLOBULIN IN OBESE RENAL TRANSPLANT PATIENTS: 8 YEAR FOLLOW UP: 105 von Laftavi, M. R., Patel, S. K., Kohli, R., Alnimri, M., Said, M., Feng, L., Laftavi, H., Pankewycz, O.

Volltext

MYCOPHENOLIC ACID (MPA) DOSE REDUCTIONS RESULT IN POOR LONG TERM RENAL ALLOGRAFT SURVIVAL: COMPARISON BETWEEN SODIUM MYCOPHENOLATE (SMPA) AND MYCOPHENOLATE MOFETIL (MMF): 2428 von Laftavi, M. R., Hai, F., Laftavi, H., Feng, L., Said, M., Alnimri, M., Kohli, R., Patel, S. K., Pankewycz, O.

Volltext